These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8385257)

  • 21. Regulation of episodic growth hormone secretion by the central epinephrine system. Studies in the chronically cannulated rat.
    Terry LC; Crowley WR; Johnson MD
    J Clin Invest; 1982 Jan; 69(1):104-12. PubMed ID: 7054231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats.
    Johnson MD; Crowley WR
    Neuroendocrinology; 1984 Apr; 38(4):322-7. PubMed ID: 6328344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat.
    Rivier C; Brown M; Vale W
    Endocrinology; 1977 Mar; 100(3):751-4. PubMed ID: 95701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
    Devorshak-Harvey E; Bona-Gallo A; Gallo RV
    Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
    Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
    Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of opiates and endogenous opioid peptides in the regulation of rat TSH secretion.
    Sharp B; Morley JE; Carlson HE; Gordon J; Briggs J; Melmed S; Hershman JM
    Brain Res; 1981 Aug; 219(2):335-44. PubMed ID: 6266605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats.
    Jezová D; Vigas M; Jurcovicová J
    Life Sci; 1982 Jul; 31(4):307-14. PubMed ID: 6292645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man.
    Chiodera P; Volpi R; Coiro V; Barilli L; Rossi G; Roti E
    J Endocrinol Invest; 1983 Oct; 6(5):381-4. PubMed ID: 6319478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine sulfate depression of cardiac function is attenuated by opiate receptor antagonism with naloxone.
    Vargish T; Beamer KC; Daly T; Riggs TR
    Circ Shock; 1987; 23(3):189-95. PubMed ID: 2827907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of pulsatile growth hormone secretion by growth-inducing exercise: involvement of endogenous opiates and somatostatin.
    Borer KT; Nicoski DR; Owens V
    Endocrinology; 1986 Feb; 118(2):844-50. PubMed ID: 2867892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual dimorphism in the control of growth hormone secretion.
    Jansson JO; Edén S; Isaksson O
    Endocr Rev; 1985; 6(2):128-50. PubMed ID: 2861084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine effects of centrally injected nociceptin in the rat.
    Netti C; Rapetti D; Sibilia V; Pagani F; Pecile A; Guidobono F
    Brain Res; 2002 May; 938(1-2):55-61. PubMed ID: 12031535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats.
    Jansson JO; Frohman LA
    Endocrinology; 1987 Oct; 121(4):1417-23. PubMed ID: 3653034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen.
    Gabriel SM; Simpkins JW; Kalra SP
    Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mu- and delta-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats.
    Idänpään-Heikkilä JJ; Rauhala P; Männistö PT
    Eur J Pharmacol; 1995 Sep; 284(1-2):227-30. PubMed ID: 8549632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of morphine on luteinizing hormone secretion and catecholamine turnover in the hypothalamus of estrogen-treated rats.
    Akabori A; Barraclough CA
    Brain Res; 1986 Jan; 362(2):221-6. PubMed ID: 3942873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.